Showing results (11-20 of 85) with videos related to

Sort By:
Pageof 9
Plos One|February 1, 2013
FOXM1 is an oncogenic mediator in Ewing SarcomaLaura Christensen, Jay Joo, Sean Lee, et al.
Cellular and Molecular Gastroenterology and Hepatology|May 16, 2022
Single-Cell Transcriptomics of Liver Cancer: Hype or Insights?Qing-Yang Zhang, Daniel Wai-Hung Ho, Yu-Man Tsui, et al.
Seminars in Cancer Biology|March 1, 2021
Cellular heterogeneity and plasticity in liver cancerLo-Kong Chan, Yu-Man Tsui, Daniel Wai-Hung Ho, et al.
Medical and Pediatric Oncology|March 29, 2002
Analysis of TP53 germline mutations in pediatric tumor patients using DNA microarray-based sequencing technologyKarl-Ludwig Schaefer, Daniel Wai, Christopher Poremba, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 13, 2010
Long-acting neuraminidase inhibitor laninamivir octanoate versus oseltamivir for treatment of influenza: A double-blind, randomized, noninferiority clinical trialAkira Watanabe, Shan-Chwen Chang, Min Ja Kim, et al.
Frontiers in Medicine|July 22, 2022
Investigation of Functional Synergism of CENPF and FOXM1 Identifies POLD1 as Downstream Target in Hepatocellular CarcinomaDaniel Wai-Hung Ho, Wai-Ling Macrina Lam, Lo-Kong Chan, et al.
Liver Cancer|October 27, 2016
Molecular Pathogenesis of Hepatocellular CarcinomaDaniel Wai-Hung Ho, Regina Cheuk-Lam Lo, Lo-Kong Chan, et al.
Pageof 9